BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 32708341)

  • 1. Salivary Biomarkers and Their Application in the Diagnosis and Monitoring of the Most Common Oral Pathologies.
    Melguizo-Rodríguez L; Costela-Ruiz VJ; Manzano-Moreno FJ; Ruiz C; Illescas-Montes R
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome.
    Baldini C; Gallo A; Perez P; Mosca M; Alevizos I; Bombardieri S
    Clin Exp Rheumatol; 2012; 30(5):785-90. PubMed ID: 23009763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saliva biomarkers in oral disease.
    Zhou Y; Liu Z
    Clin Chim Acta; 2023 Aug; 548():117503. PubMed ID: 37536520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivaomics for oral diseases biomarkers detection.
    Tasoulas J; Patsouris E; Giaginis C; Theocharis S
    Expert Rev Mol Diagn; 2016; 16(3):285-95. PubMed ID: 26680995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Proteomics of Saliva in Sjögren's Syndrome.
    Katsiougiannis S; Wong DT
    Rheum Dis Clin North Am; 2016 Aug; 42(3):449-56. PubMed ID: 27431347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action.
    Kaur J; Politis C; Jacobs R
    Clin Oral Investig; 2016 Mar; 20(2):315-9. PubMed ID: 26077895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Mucin-7 (Muc7) Sialylation and Altered Saliva Rheology in Sjögren's Syndrome Associated Oral Dryness.
    Chaudhury NM; Proctor GB; Karlsson NG; Carpenter GH; Flowers SA
    Mol Cell Proteomics; 2016 Mar; 15(3):1048-59. PubMed ID: 26631508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
    Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
    Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic diagnosis of Sjögren's syndrome.
    Giusti L; Baldini C; Bazzichi L; Bombardieri S; Lucacchini A
    Expert Rev Proteomics; 2007 Dec; 4(6):757-67. PubMed ID: 18067414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining salivary biomarkers using mass spectrometry-based proteomics: a systematic review.
    Al-Tarawneh SK; Border MB; Dibble CF; Bencharit S
    OMICS; 2011 Jun; 15(6):353-61. PubMed ID: 21568728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saliva as a potential diagnostic tool.
    Deepa T; Thirrunavukkarasu N
    Indian J Med Sci; 2010 Jul; 64(7):293-306. PubMed ID: 22918070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren's syndrome.
    Delaleu N; Mydel P; Kwee I; Brun JG; Jonsson MV; Jonsson R
    Arthritis Rheumatol; 2015 Apr; 67(4):1084-95. PubMed ID: 25545990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic significance of salivary levels of beta 2-microglobulin in Sjögren's syndrome.
    Swaak AJ; Visch LL; Zonneveld A
    Clin Rheumatol; 1988 Mar; 7(1):28-34. PubMed ID: 3044671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of aquaporin 3 and 5 as a potential marker for distinguishing dry mouth from Sjögren's syndrome.
    Ichiyama T; Nakatani E; Tatsumi K; Hideshima K; Urano T; Nariai Y; Sekine J
    J Oral Sci; 2018; 60(2):212-220. PubMed ID: 29925705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saliva: a potential media for disease diagnostics and monitoring.
    Liu J; Duan Y
    Oral Oncol; 2012 Jul; 48(7):569-77. PubMed ID: 22349278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of salivary glycopatterns in oral lichen planus.
    Fang L; Liu Q; He P; Wang X; Wang Y; Wei M; Chen L
    Biomarkers; 2018 Mar; 23(2):188-195. PubMed ID: 29130773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines Levels and Salivary Microbiome Play A Potential Role in Oral Lichen Planus Diagnosis.
    Carvalho MFMS; Cavalieri D; Do Nascimento S; Lourenço TGB; Ramos DVR; Pasqualin DDC; Martins LAL; Rocha FA; Heller D; Marti L
    Sci Rep; 2019 Dec; 9(1):18137. PubMed ID: 31792433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
    Beckman KA; Luchs J; Milner MS; Ambrus JL
    Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysozyme determination in parotid saliva from patients with Sjögren's syndrome.
    Moutsopoulos HM; Karsh J; Wolf RO; Tarpley TM; Tylenda A; Papadopoulos NM
    Am J Med; 1980 Jul; 69(1):39-42. PubMed ID: 7386505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible salivary and serum biomarkers for oral lichen planus.
    Totan A; Miricescu D; Parlatescu I; Mohora M; Greabu M
    Biotech Histochem; 2015; 90(7):552-8. PubMed ID: 25839238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.